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Ventricular ectopic beats (VEBs) have been described in
approximately 1% of clinically normal persons as detected by
standard electrocardiogram (ECG) (1), and in 40% to 75%
of apparently healthy persons as detected by 24 to 48 h of
continuous ambulatory (Holter) ECG (2–5). Both the
incidence and the frequency of VEBs increase with age
(2,5), and even frequent (60/h or 1/min) and complex
(involving multiform, alternating or repetitive patterns or R
on T beats) VEBs occur in apparently healthy subjects
(5–9). Such individuals constitute an estimated prevalence
of 1% to 4% of the general population (6). Nevertheless,
VEBs in apparently healthy persons have been the genesis of
concern and anxiety to both patients and physicians ever
since the earliest reports of an irregular pulse. This is
particularly true when such ventricular ectopy is either
frequent and/or complex, because the latter arrhythmias
identify a subset of patients in cardiovascular disease popu-
lations at increased risk of death and sudden cardiac death
(10–12). Never is physician concern more heightened as
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when these cardiac arrhythmias occur in young people
engaged in strenuous activities such as competitive athletics
(13). Whereas the risk of sudden cardiac death in high
school athletes has been shown to be small (approximately
one in 200,000 per year) and is usually due to underlying
(and usually unsuspected) structural cardiovascular disease
(14,15), nevertheless the detection of frequent and/or com-
plex VEBs in a competitive athlete who appears to be
apparently healthy engenders physician apprehension and a
cautious attitude as to whether its occurrence is benign or
potentially life-threatening.
Since 1985 it has been generally accepted that when
frequent and/or complex VEBs are detected in apparently
healthy persons who are thoroughly examined by modern
noninvasive cardiologic diagnostic methods (i.e., history and
physical examination, standard and ambulatory ECG, ex-
ercise stress testing and echocardiogram) and are found to
have no evidence of structural heart disease, it is a benign
condition with a favorable prognosis (6–9). This perspective
was particularly germane in the 1980s when antiarrhythmic
therapy was found to aggravate or provoke proarrhythmia
(16), and the discovery that not infrequently antiarrhythmic
medications prescribed to apparently healthy persons for
VEBs was the etiologic agent of out-of-hospital sudden
death (17). Subsequently, this evidence led to the clinical
dictum that such persons should not be treated with
antiarrhythmic medications. If subjects are symptomatic
with minor palpitations, a recommendation to withdraw
stimulants (caffeine, alcohol, smoking, etc.) is advised, and if
symptoms continue to be worrisome to the patient, beta-
blocker therapy is recommended (6). This viewpoint has on
occasion been challenged (18), and when such reports are
critically examined they seem to result from populations not
thoroughly examined noninvasively to exclude structural
cardiac disease (19).
Athletes, however, constitute a different but apparently
healthy population. Twenty-four-hour continuous ambula-
tory ECG studies have shown a higher prevalence of VEBs
(70%) and frequent and/or complex forms (25% to 63%) in
athletic populations (20). Moreover, top-level or highly
trained athletes can show morphologic changes of the
“athlete’s heart,” which include increased left ventricular
mass, wall thickness and cavity dimensions (21,22). These
changes result as a consequence of several determinants,
which include type of sport, gender and probable genetic
factors (22,23). The extent of physiologic cardiac remodel-
ing in some highly trained individuals may pose a physician
dilemma of suspected structural cardiac disease, particularly
when standard ECG abnormalities have been encountered
in as many as 40% of one population of 1,005 elite athletes
(22). Athletes may demonstrate a spectrum of ECG alter-
ations that include increased R- or S-wave voltages, ST-
segment or T-wave changes and deep Q waves suggestive of
left ventricular hypertrophy or cardiomyopathy (22). A
recent meta-analysis of 59 studies of 1,451 athletes showed
that an athlete’s heart has divergent adaptation to dynamic
and static sports with an endurance-trained heart (eccentric
hypertrophy) and a strength-trained heart (concentric hy-
pertrophy) not being an absolute and dichotomous concept
(24,25). Subsequent ranking of sports was therefore based
on the impact of training on left ventricular diastolic cavity
dimension and left ventricular wall thickness (24,25). Pro-
spective studies have further shown that detraining with a
long-term deconditioning period (1 to 13 years; mean 5.6
years) results in left ventricular remodeling with significant
reduction in cavity size and normalization of wall thickness
(26). However, resolution of cavity enlargement is incom-
plete in most cases, and substantial chamber dilation can
persist in more than 20% of athletes (26).
The report by Biffi et al. (27) in this issue of the Journal
describes a selected population of 355 athletes encountered
over a 15-year period (1984 to 1999) who were identified or
referred because of the presence of 3 VEBs on a standard
ECG or the complaint of palpitations, and who were
subsequently examined by continuous ambulatory ECG.
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The cohort of 355 represented 2.3% of 15,889 athletes
examined by the Institute of Sports Science of the Italian
National Olympic Committee (27). Each of the 355 ath-
letes (mean age 24.8 years; range 14 to 35 years) had
previously received a cardiovascular evaluation consisting of
history and physical examination, standard 12-lead ECG,
echocardiogram, symptom-limited exercise test and chest
X-ray. Based on clinical judgment and the degree of
ventricular ectopy observed on ambulatory ECG, some
athletes underwent further testing by magnetic resonance
imaging (MRI) (n  42), nuclear scintigraphy (n  16),
endomyocardial biopsy (n  10) and electrophysiologic
study with programmed ventricular stimulation (n  24).
Athletes were engaged in 18 different sports with training
program durations of 1 to 13 years (median 4 years). Of the
athletes, 70% (n  245) had competed at the national level
of competition, and 30% (n  110) had achieved interna-
tional recognition in World Championship and Olympic
games (27).
Subsequent medical follow-up every 6 to 12 months was
accomplished over a period of 2 to 15 years (mean 8.4 6.3
years). Based on previous ambulatory ECG data of normal
populations (5), the investigators (27) arbitrarily divided
their data into groups A, 71 athletes with2,000 VEBs and
1 episode of nonsustained ventricular tachycardia
(NSVT)/24-h period; group B, 153 athletes with 2,000
but 100 VEBs without NSVT/24-h period; and group C,
131 athletes with 100 VEBs and without NSVT/24-h
period. The latter group C athletes without complex forms
or NSVT essentially demonstrated the same frequency of
ventricular ectopy previously reported in normal population
data (2–6). Overall examination disclosed that 93% (n 
329) of athletes demonstrated no evidence of structural
cardiovascular abnormality, while 7% (n  26) of athletes
showed abnormalities of mitral valve prolapse with mitral
regurgitation (n  11), arrhythmogenic right ventricular
cardiomyopathy (n  7), myocarditis (n  4) and dilated
cardiomyopathy (n  4). Whereas athletes with cardiovas-
cular abnormalities were detected only in the presence of
very frequent VEBs (groups A and B), their ventricular
arrhythmias were not significantly different from other
athletes in those groups without cardiovascular abnormali-
ties. The VEB morphology of left bundle branch block
pattern with inferior axis (i.e., right ventricular origin)
previously described in normal populations was found dom-
inant in all groups (65% to 78%), and the occurrence of right
bundle branch block patterns suggesting left ventricular or
septal origin did not significantly differ among the groups
(27). Use of enhanced diagnostic methods (i.e., MRI,
nuclear scintigraphy, myocardial biopsies and electrophysi-
ologic study) contributed to the detection of cardiovascular
abnormalities in 14 of the 26 subjects found to have
abnormalities. All 71 athletes of group A were disqualified
from competitive sports for a minimum of three months
based on the Italian guidelines for determining eligibility
(28), and during a mean follow-up of 8.4 years (range 2 to
15 years) only one athlete (who was previously disqualified)
with arrhythmogenic right ventricular cardiomyopathy died
suddenly while engaging (against medical advice) in a
field-hockey game (27).
The longitudinal data of Biffi et al. (27) represent the
largest cohort of apparently healthy persons (including
athletes) identified with frequent and/or complex VEBs
who have been followed prospectively for clinical outcomes
(2–9). The Biffi et al. (27) data confirm the clinical axiom
that frequent and/or complex occurrence of VEBs in appar-
ently healthy subjects does not confer an ominous prognosis
in the absence of structural heart disease (6–9); their
findings extend that observation to athletes subjected to the
unique environmental conditions and stress of intense ex-
ercise training and competition (with neurohumoral alter-
ations in blood volume, electrolytes and the autonomic
nervous system). A minority of the cohort (eight with
detected cardiovascular abnormalities) received drug ther-
apy, which was predominantly beta-blocker therapy. Sur-
prisingly, the population identified by Biffi et al. (27) did not
identify individuals with hypertrophic cardiomyopathy or
coronary anomalies thought to be the most common car-
diovascular abnormalities associated with sudden death in
athletes (14,15). Whether such persons were selected out by
family history or echocardiography, went undetected or did
not enter the cohort because of a lack of frequent VEBs is
a matter of speculation. Nevertheless, the presence of
frequent and/or complex VEBs did not indicate an adverse
prognosis in the athletes without cardiovascular structural
abnormalities. A limitation of the current report encoun-
tered in all long-term investigations is the inability to
apply emerging methods and science currently available
to the investigation of their subjects. Still, the omission
of concurrent data of the standard ECG abnormalities
encountered, which may have defined the presence or lack of
“athlete’s heart” patterns or repolarization abnormalities asso-
ciated with the frequent and/or complex VEBs measured, is a
limitation.
The report, however, does focus attention on the chang-
ing medical concept of without structural cardiac abnormal-
ities, which has evolved over time with emerging medical
technology and scientific discovery. Biffi et al. (27) did not
examine all subjects with extensive noninvasive or invasive
methods, but they selected clinically those subjects of
greatest concern to utilize MRI, nuclear scintigraphy, myo-
cardial biopsy or electrophysiologic testing. Although the
pathogenesis of frequent and/or complex VEBs in appar-
ently healthy subjects continues to be confounded by mul-
tiple mechanisms, early studies have defined subtle abnor-
malities of ventricular contractility by cineangiography (29),
evidence of lymphocytic or old myocarditis (30,31), the
presence of left ventricular false tendons (32) or adrenergic
innervation abnormalities (33) as possible causative mecha-
nisms of the VEBs. More recent MRI and cine-MRI
investigations have called attention to detection of right
ventricular outflow tract enlargement in the transverse and
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anteroposterior axis diameter, and anterior/lateral wall mo-
tion abnormalities with or without bulging in the right
ventricular outflow tract of subjects with frequent and/or
complex VEBs (34). Finally, the presence of focal ventric-
ular Purkinje abnormalities as a triggering etiology of
frequent VEBs has been demonstrated by electrophysiologic
study and radiofrequency catheter ablation studies of pa-
tients with severely symptomatic VEBs (35–38), although
such treatment has been viewed with editorial concern
(39,40). One can speculate that in the present study ven-
tricular dilation and/or hypertrophy defined in previous
investigations of the “athlete’s heart” was a contributing
factor to the genesis of the frequent VEBs found.
In future studies of both athletic and apparently healthy
populations with frequent and/or complex VEBs, it is to be
hoped that an algorithm resulting from the findings of the
conventional diagnostic examinations will define more
clearly when utilization of extended diagnostic methods are
indicated. Utilization of MRI and cine-MRI, endomyocar-
dial biopsies and genetic studies probably can identify the
small subset of subjects with covert cardiac disorders who
warrant physician concern. In the meantime, practicing
physicians can continue to take solace in the good news that
the subject with frequent and/or complex VEBs, who is
thoroughly examined with conventional noninvasive cardio-
vascular diagnostic methods and found to have no evidence
of structural cardiac disease, is at low risk of sudden cardiac
death . . . even if he or she is an athlete engaged in com-
petitive sports.
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